About Matthew Mitcho
Form D filings for Gemelli Biotech from 2019 to 2024 list Matthew Mitcho as chief executive officer and director.
Matthew Mitcho first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Mitcho in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Mitcho works with at each company, as listed on that company's latest Form D.
Gemelli Biotech Corp. · Form D/A, Dec 2, 2024